Riccardo Candido
Overview
Explore the profile of Riccardo Candido including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossi A, Masi D, Zilich R, Baccetti F, Baronti W, Falcetta P, et al.
Cardiovasc Diabetol
. 2025 Feb;
24(1):94.
PMID: 40022078
Background: Hypercholesterolemia is a major cardiovascular risk factor, particularly in individuals with type 2 diabetes (T2DM), where cardiovascular events are more prevalent. Adherence to low-density lipoprotein cholesterol (LDL-c) targets remains...
2.
Avogaro A, Buzzetti R, Candido R, De Cosmo S, Notarianni L, Consolo E, et al.
Diabetes Res Clin Pract
. 2025 Feb;
:112055.
PMID: 40020784
People with diabetes mellitus (DM) are at a higher risk (2 to 4 times) for cardiovascular (CV) death and atherosclerotic CV disease (ASCVD) than the general population. A multifactorial approach...
3.
Lenarda A, Radini D, Russo G, Bollini M, Cappelletto C, Cherubini A, et al.
G Ital Cardiol (Rome)
. 2024 Dec;
26(1):29-37.
PMID: 39714498
The world of chronic non-communicable diseases is progressively growing epidemiologically, requiring a significant commitment of resources, continuity of care, and strong integration between healthcare professionals and care settings. The National...
4.
De Cosmo S, Pontremoli R, Giandalia A, Manicardi V, Rocca A, Nicolucci A, et al.
J Nephrol
. 2024 Dec;
PMID: 39676127
Background: We evaluated the proportion of Type 2 diabetes (T2D) patients with chronic kidney disease (CKD) participating in the AMD (Association of Medical Diabetologists) Annals initiative who met the eligibility...
5.
Candido R, Toffoli B, Manfredi G, Turisani A, Delfauro V, Petrucco A, et al.
Acta Diabetol
. 2024 Nov;
PMID: 39527298
Background: Gestational diabetes mellitus (GDM) affects roughly 14% of pregnancies, its prevalence is increasing, and it is associated with a significant risk of complications for both mother and offspring. A...
6.
Russo G, Nicolucci A, Lucisano G, Rossi M, Ceriello A, Prattichizzo F, et al.
Diabetes
. 2024 Oct;
74(1):75-81.
PMID: 39418322
Article Highlights:
7.
Russo G, Giandalia A, Lucisano G, Rossi M, Piscitelli P, Pontremoli R, et al.
Eur J Intern Med
. 2024 Aug;
130:123-129.
PMID: 39129121
Background: Diabetic kidney disease is the most common cause of end-stage kidney disease (ESKD) in the western world. Rapid estimated glomerular filtration rate (eGFR) decline is an independent predictor of...
8.
Russo G, Manicardi V, Rocca A, Nicolucci A, Giandalia A, Lucisano G, et al.
Metab Syndr Relat Disord
. 2024 Aug;
22(9):661-668.
PMID: 39088376
Familial chylomicronemia syndrome (FCS) is a rare inherited condition due to lipoprotein lipase deficiency, characterized by hyperchylomicronemia and severe hypertriglyceridemia. Diagnosis is often delayed, thus increasing the risk of acute...
9.
Musacchio N, Zilich R, Masi D, Baccetti F, Nreu B, Bruno Giorda C, et al.
Int J Med Inform
. 2024 Jul;
190:105550.
PMID: 39059083
Aims: This study aimed to identify and categorize the determinants influencing the intensification of therapy in Type 2 Diabetes (T2D) patients with suboptimal blood glucose control despite metformin monotherapy. Methods:...
10.
Candido R, Di Loreto C, Desenzani P, Pantanetti P, Romano C, Settembrini S, et al.
Diabetes Ther
. 2024 Jul;
15(9):1963-1977.
PMID: 39039353
From clinical trials and observational data, oral semaglutide has proven to be the most effective second-line oral therapy for the management of patients with type 2 diabetes. This review aims...